Cargando…

Outcomes of childhood severe malaria: a comparative of study pre-COVID-19 and COVID-19 periods

BACKGROUND: The collateral damages from measures adopted to mitigate the coronavirus disease 2019 (COVID-19) pandemic have been projected to negatively impact malaria in sub-Saharan Africa. Herein, we compare the prevalence and outcomes of childhood severe malaria during the pre-COVID-19 and COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahim, Olayinka Rasheed, Alao, Michael Abel, Suleiman, Bello Mohammed, Mokuolu, Olugbenga Ayodeji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105138/
https://www.ncbi.nlm.nih.gov/pubmed/37061668
http://dx.doi.org/10.1186/s12887-023-03985-4
_version_ 1785026155177312256
author Ibrahim, Olayinka Rasheed
Alao, Michael Abel
Suleiman, Bello Mohammed
Mokuolu, Olugbenga Ayodeji
author_facet Ibrahim, Olayinka Rasheed
Alao, Michael Abel
Suleiman, Bello Mohammed
Mokuolu, Olugbenga Ayodeji
author_sort Ibrahim, Olayinka Rasheed
collection PubMed
description BACKGROUND: The collateral damages from measures adopted to mitigate the coronavirus disease 2019 (COVID-19) pandemic have been projected to negatively impact malaria in sub-Saharan Africa. Herein, we compare the prevalence and outcomes of childhood severe malaria during the pre-COVID-19 and COVID-19 periods at a tertiary health facility in Nigeria. METHODS: This was a retrospective review of cases of severe malaria admitted from 1st January to 31st December 2019 (pre-COVID-19 period) and 1st January to 31st December 2020 (COVID-19 period). We extracted relevant information, including demographics, the duration of symptoms before presentation, forms of severe malaria, and outcomes of hospitalization (discharged or death). RESULTS: In the pre-COVID-19 period, there were a total of 2312 admissions to the EPU and 1685 in the COVID-19 period, representing a decline of 27%. In contrast, there were 263 and 292 severe malaria admissions in the pre-COVID-19 and COVID-19 periods, respectively, representing an 11% increase in the absolute number of cases. The prevalence rates were 11.4% in the pre-COVID-19 period and 17.3% in the COVID-19 period, representing an increase of 52% in the percentage differences. The mortality rate in the COVID-19 period was higher than the pre-COVID-19 period ([10.3%; 30/292 vs. 2.3%; 6/263], p 0.001). The death rate increased by 350% during the COVID-19 period. The odds ratio (OR) of a child dying from severe malaria in the COVID-19 era was 4.9 [95% confidence interval (CI): 2.008 to 11.982]. In the COVID-19 era, presentation at a health facility was also delayed (p = 0.029), as were the odds of multiple features of severe malaria manifestations (OR-1.9, 95% CI, 1.107 to 3.269; p = 0.020). CONCLUSION: This study shows that the prevalence of severe childhood malaria increased by as much as 11.0%, with a disproportionate increase in mortality compared to the pre-pandemic level. Most children with severe malaria presented late with multiple features of severe malaria, probably contributing to the poor hospitalization outcomes (death) observed in this study.
format Online
Article
Text
id pubmed-10105138
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-101051382023-04-16 Outcomes of childhood severe malaria: a comparative of study pre-COVID-19 and COVID-19 periods Ibrahim, Olayinka Rasheed Alao, Michael Abel Suleiman, Bello Mohammed Mokuolu, Olugbenga Ayodeji BMC Pediatr Research BACKGROUND: The collateral damages from measures adopted to mitigate the coronavirus disease 2019 (COVID-19) pandemic have been projected to negatively impact malaria in sub-Saharan Africa. Herein, we compare the prevalence and outcomes of childhood severe malaria during the pre-COVID-19 and COVID-19 periods at a tertiary health facility in Nigeria. METHODS: This was a retrospective review of cases of severe malaria admitted from 1st January to 31st December 2019 (pre-COVID-19 period) and 1st January to 31st December 2020 (COVID-19 period). We extracted relevant information, including demographics, the duration of symptoms before presentation, forms of severe malaria, and outcomes of hospitalization (discharged or death). RESULTS: In the pre-COVID-19 period, there were a total of 2312 admissions to the EPU and 1685 in the COVID-19 period, representing a decline of 27%. In contrast, there were 263 and 292 severe malaria admissions in the pre-COVID-19 and COVID-19 periods, respectively, representing an 11% increase in the absolute number of cases. The prevalence rates were 11.4% in the pre-COVID-19 period and 17.3% in the COVID-19 period, representing an increase of 52% in the percentage differences. The mortality rate in the COVID-19 period was higher than the pre-COVID-19 period ([10.3%; 30/292 vs. 2.3%; 6/263], p 0.001). The death rate increased by 350% during the COVID-19 period. The odds ratio (OR) of a child dying from severe malaria in the COVID-19 era was 4.9 [95% confidence interval (CI): 2.008 to 11.982]. In the COVID-19 era, presentation at a health facility was also delayed (p = 0.029), as were the odds of multiple features of severe malaria manifestations (OR-1.9, 95% CI, 1.107 to 3.269; p = 0.020). CONCLUSION: This study shows that the prevalence of severe childhood malaria increased by as much as 11.0%, with a disproportionate increase in mortality compared to the pre-pandemic level. Most children with severe malaria presented late with multiple features of severe malaria, probably contributing to the poor hospitalization outcomes (death) observed in this study. BioMed Central 2023-04-15 /pmc/articles/PMC10105138/ /pubmed/37061668 http://dx.doi.org/10.1186/s12887-023-03985-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ibrahim, Olayinka Rasheed
Alao, Michael Abel
Suleiman, Bello Mohammed
Mokuolu, Olugbenga Ayodeji
Outcomes of childhood severe malaria: a comparative of study pre-COVID-19 and COVID-19 periods
title Outcomes of childhood severe malaria: a comparative of study pre-COVID-19 and COVID-19 periods
title_full Outcomes of childhood severe malaria: a comparative of study pre-COVID-19 and COVID-19 periods
title_fullStr Outcomes of childhood severe malaria: a comparative of study pre-COVID-19 and COVID-19 periods
title_full_unstemmed Outcomes of childhood severe malaria: a comparative of study pre-COVID-19 and COVID-19 periods
title_short Outcomes of childhood severe malaria: a comparative of study pre-COVID-19 and COVID-19 periods
title_sort outcomes of childhood severe malaria: a comparative of study pre-covid-19 and covid-19 periods
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105138/
https://www.ncbi.nlm.nih.gov/pubmed/37061668
http://dx.doi.org/10.1186/s12887-023-03985-4
work_keys_str_mv AT ibrahimolayinkarasheed outcomesofchildhoodseveremalariaacomparativeofstudyprecovid19andcovid19periods
AT alaomichaelabel outcomesofchildhoodseveremalariaacomparativeofstudyprecovid19andcovid19periods
AT suleimanbellomohammed outcomesofchildhoodseveremalariaacomparativeofstudyprecovid19andcovid19periods
AT mokuoluolugbengaayodeji outcomesofchildhoodseveremalariaacomparativeofstudyprecovid19andcovid19periods